Advertisement
Home Tags Kidney Problems: Misc.

Tag: Kidney Problems: Misc.

The occurrence of nephrogenic systemic fibrosis appears to be rare after exposure to newer gadolinium-based contrast agents

Nephrogenic Systemic Fibrosis Rare With Newer GBCA Exposure

0
Data scant on exposure to gadolinium-based contrast agents for those with acute kidney injury, risk for CKD
Patients who report choosing dialysis to please doctors or family members more often report decisional regret

Decision Regret Increased for Those Who Choose Dialysis to Please Others

0
Dialysis decision regret less likely for those who discuss prognosis with doctors, complete living will
Patients admitted to a New York City hospital with COVID-19 faced major morbidity and mortality

Acute Kidney Injury Common in COVID-19 Patients at NYC Hospital

0
Of patients admitted to ICU, 78.0 percent developed acute kidney injury, 35.2 percent needed dialysis

May 2020 Briefing – Nephrology

0
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for May 2020. This roundup includes the latest...
Patient factors account for much of the variation in access to kidney transplantation in the United Kingdom

Inequity Found in Access to Transplant With Universal Health Care

0
Patient factors including socioeconomic status account for much variation in kidney transplant access
Patients initiating hemodialysis often are prescribed opioids and short-acting benzodiazepines

Benzodiazepines, Codispensed Opioids Common in Hemodialysis

0
Risk for mortality increased for those receiving short-acting benzodiazepines alone or with opioids
Increased exposure to heavy metal lead

Environmental Chemical Exposure Tied to Kidney Disease in the U.S.

0
Researchers identify link between seven chemicals and chronic kidney disease
Among patients with kidney failure

SES Mediates Racial Differences in Kidney Transplant Listing

0
Socioeconomic status and comorbidity attenuate racial differences in transplant listing, not receipt
Use of sodium-glucose cotransporter 2 inhibitors is associated with a reduced risk for serious renal events compared with dipeptidyl peptidase-4 inhibitors

SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events

0
Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors

April 2020 Briefing – Nephrology

0
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for April 2020. This roundup includes the latest...